Cancer Breakthrough: BriaCell (Nasdaq: $BCTX) reports disease control, tumor shrinkage and potential survival benefit among 70% of the patients enrolled in its 2021-2022 group of advanced breast cancer patients!
New CEO Interview
https://yhoo.it/3EzQmij
#Stocks #Nasdaq $BCTX